Prospective, longitudinal study of cancer predictors and rates in a New York City cohort of 598 patients with acromegaly.
Pamela U FredaJeffrey N BruceZhezhen JinJane KostadinovAlexander G KhandjiSerge CremersKalmon D PostPublished in: The Journal of clinical endocrinology and metabolism (2024)
Cancer risk is increased in acromegaly, but not in CNFPA patients. Cumulative exposure to IGF-1 excess is a predictor of cancer in acromegaly. Our data suggest that cancer risk in acromegaly relates to the degree and duration of IGF-1 excess and that full appreciation of this risk requires long-term follow up.